Fast Eddie said:
Well said. In the best case this will all come down to patients and surgeons looking at the trial data and determining if the risk of using Plavix/aspirin vs Coumadin is within their comfort zone. Worst case we're on Coumadin till a better valve comes along.
Fast Eddie
For good reason, there is a LOT of interest in the Plavix / Aspirin Study.
Since I will be on Coumadin for LIFE because of my St. Jude mechanical valve in the Aortic position, this issue has little relevance to ME.
The (often overlooked) reasons that I chose an On-X Valve for my pending Mitral Valve Replacement is more basic.
#1 - The Mitral Valve is more likely to form Clots than the Aortic Vavle.
#2 - The On-X Valve has less turbulence, causes less damage to blood cells, and is the LEAST LIKELY to form CLOTS of any of the Mechanical Valves on the market today, especially with NO anticoagulation (i.e. when invasive procedures are called for).
This conclusion is supported by the South African study (performed and published by South Africans) with a largely non-compliant or non-anticoagulated population. (It is not clear to me what role On-X played in that study other than to manufacture and supply the valves).
Note that there are several GOOD mechanical valves, but the early (5 year) numbers I have seen support the On-X valve as having the LOWEST Morbid Event Rate.
I do NOT feel it would be proper for ME to bash other manufacturers publicly. That is why I encourage anyone interested in pursuing this research to do so on their own.
The EXTENSIVE information package from On-X identifies the major players and gives what they believe to be reliable and accurate numbers. Interested parties should verify these numbers from the other manufacturers if they are so inclined.
'AL Capshaw'